Cancer Bioinformatics: From Therapy Design to Treatment

1. Edition January 2006
300 Pages, Hardcover
Wiley & Sons Ltd
Short Description
Cancer bioinformatics is emerging as a new interdisciplinary field, encouraging an unprecedented synthesis of knowledge from the life and clinical sciences. The first book dedicated to the role of bioinformatics applied to cancer research and therapy, Cancer Bioinformatics provides a comprehensive, up-to-date review of this growing field, from laboratory work to clinical trials. With contributions from leaders in the fields of clinical oncology, cancer research, and bioinformatics, it offers balanced coverage of key topics in these fields, from well-established techniques to emergent approaches.
The emerging field of cancer bioinformatics is facilitating an unprecedented synthesis of knowledge arising from the life and clinical sciences. The complexity of the questions being addressed requires experts from diverse backgrounds to engage in close and ongoing discourse and collaboration. They therefore need to be familiar with the research questions, terminology and methodology of the specialists in related subject areas.
The primary aim of the book is to provide a comprehensive and up-to-date account of the enormous range of bioinformatics techniques now being developed for cancer research and therapy, from the laboratory to clinical trials. It will function as a guide to integrated data exploitation and synergistic knowledge discovery, and support the consolidation of the multidisciplinary research community involved.
The book features a balanced range of topics, including both well-established techniques and emergent approaches in genomics, systems biology and e-science. Each chapter delivers an overview of the topic, combined with more detailed technical descriptions of key aspects of informatics, biology and clinical science. With contributions from clinical oncologists, research scientists, bioinformaticians and mathematical modellers, the book will facilitate scientific dialogue and collaboration across disciplinary boundaries. Finally, three chapters on the ethical and legal implications of cancer bioinformatics provide an expanded view of these groundbreaking developments and how they may impact on patients and other health care stakeholders.
This multidisciplinary book will be of interest to a broad audience including clinical oncologists, basic researchers in both academia and industry, computer scientists/bioinformaticians, clinical trial managers, ethicists and ethics boards.
List of Contributors.
SECTION I CANCER SYSTEMS.
1 A Path to Knowledge: from Data to Complex Systems Models of Cancer (Sylvia Nagl).
2 Theory of Cancer Robustness (Hiroaki Kitano).
3 Developing an Integrated Informatics Platform for Cancer Research (Richard Begent).
SECTION II In silico MODELS.
4 Mathematical Models of Cancer (Manish Patel and Sylvia Nagl).
5 Some Mathematical Modelling Challenges and Approaches in Cancer (Philip Maini and Robert A. Gatenby).
6 Computer Simulation of Tumour Response to Therapy (Georgios S. Stamatakos and Nikolaos Uzunoglu).
7 Structural Bioinformatics in Cancer (Stephen Neidle).
SECTION III In vivo MODELS.
8 The Mouse Tumour Biology Database: an Online Resource for Mouse Models of Human Cancer (Carol J. Bult, Debra M. Krupke, Matthew J. Vincent, Theresa Allio, John P. Sundberg, Igor Mikaelian and Janan T. Eppig).
9 Bioinformatics Approaches to Integrate Cancer Models and Human Cancer Research (Cheryl L. Marks and Sue Dubman).
SECTION IV DATA.
10 The FAPESP/LICR Human Cancer Genome Project: Perspectives on Integration (Ricardo Brentani, Anamaria A. Camargo, Helena Brentani and Sandro J. De Souza).
11 Today's Science, Tomorrow's Patient: the Pivotal Role of Tissue, Clinical Data and Informatics in Modern Drug Development (Kirstine Knox, Amanda Taylor and David J. Kerr).
SECTION V ETHICS.
12 Software Design Ethics for Biomedicine (Don Gotterbarn and Simon Rogerson).
13 Ethical Issues of Electronic Patient Data and Informatics in Clinical Trial Settings (Dipak Kalra and David Ingram).
14 Pharmacogenomics and Cancer: Ethical, Legal and Social Issues (Mary Anderlik Majumder and Mark Rothstein).
Index
"...good reading for anyone entering into some aspect of cancer research, whether it is biological, mathematical, or computational..." (Biometrics, December 2006)
"Overall ... an excellent and well-edited book that could be read from cover to cover or used as a reference." (British Journal of Healthcare Computing and Information Management, July 2006)